Litcius/Paper detail

P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events

Felice Gragnano, Davide Cao, Leah Pirondini, Anna Franzone, Hyo‐Soo Kim, Moritz von Scheidt, Alf‐Åge R. Pettersen, Qiang Zhao, Mark Woodward, Mauro Chiarito, Eugène McFadden, Kyung Woo Park, Adnan Kastrati, Ingebjørg Seljeflot, Yunpeng Zhu, Stephan Windecker, Jeehoon Kang, Heribert Schunkert, Harald Arnesen, Deepak L. Bhatt, Philippe Gabríel Steg, Paolo Calabrò, Stuart Pocock, Roxana Mehran, Marco Valgimigli

2023Journal of the American College of Cardiology178 citationsDOI

Topics & Concepts

MedicineTicagrelorAspirinInternal medicineClopidogrelP2Y12Myocardial infarctionCoronary artery diseaseStroke (engine)Adverse effectAcute coronary syndromeRandomized controlled trialPlatelet aggregation inhibitorCardiologyEngineeringMechanical engineeringAntiplatelet Therapy and Cardiovascular DiseasesInflammatory mediators and NSAID effectsAcute Myocardial Infarction Research